Product Brochure
Introduction to eLAS®
![Introduction to eLAS®](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/pharmaceutical-science/outsourcing-pharma.com/resources/data-management/introduction-to-elas-r/12240566-1-eng-GB/Introduction-to-eLAS-R.png)
Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus erythematosus (SLE) studies and the integrity of the study endpoints.
eLAS is a therapeutic-specific application of Clinical Ink’s Lunexis™. Unlike other applications that simply offer stand-alone electronic versions of questionnaires, eLAS features a fully integrated suite of SLE disease assessment questionnaires, physical assessment, tender/swollen joint count, PGA, and summary forms.